- Home
- RLAY vs CGNT Comparison
RLAY vs CGNT Comparison
Compare RLAY & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- CGNT
- Stock Information
- Founded
- RLAY 2015
- CGNT 2020
- Country
- RLAY United States
- CGNT Israel
- Employees
- RLAY N/A
- CGNT N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- CGNT Computer Software: Prepackaged Software
- Sector
- RLAY Health Care
- CGNT Technology
- Exchange
- RLAY Nasdaq
- CGNT Nasdaq
- Market Cap
- RLAY 576.1M
- CGNT 669.2M
- IPO Year
- RLAY 2020
- CGNT N/A
- Fundamental
- Price
- RLAY $3.63
- CGNT $8.93
- Analyst Decision
- RLAY Strong Buy
- CGNT Hold
- Analyst Count
- RLAY 11
- CGNT 1
- Target Price
- RLAY $18.40
- CGNT N/A
- AVG Volume (30 Days)
- RLAY 1.6M
- CGNT 450.8K
- Earning Date
- RLAY 08-05-2025
- CGNT 06-11-2025
- Dividend Yield
- RLAY N/A
- CGNT N/A
- EPS Growth
- RLAY N/A
- CGNT N/A
- EPS
- RLAY N/A
- CGNT N/A
- Revenue
- RLAY $7,679,000.00
- CGNT $363,466,000.00
- Revenue This Year
- RLAY $14.31
- CGNT $14.94
- Revenue Next Year
- RLAY N/A
- CGNT $9.57
- P/E Ratio
- RLAY N/A
- CGNT N/A
- Revenue Growth
- RLAY N/A
- CGNT 12.58
- 52 Week Low
- RLAY $1.78
- CGNT $6.21
- 52 Week High
- RLAY $10.72
- CGNT $11.66
- Technical
- Relative Strength Index (RSI)
- RLAY 63.22
- CGNT 41.91
- Support Level
- RLAY $3.10
- CGNT $9.08
- Resistance Level
- RLAY $3.75
- CGNT $9.49
- Average True Range (ATR)
- RLAY 0.23
- CGNT 0.30
- MACD
- RLAY 0.03
- CGNT -0.02
- Stochastic Oscillator
- RLAY 84.42
- CGNT 49.13
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.